[1]
2024. Management of Rheumatologic Immune-Related Adverse Events (Rh-irAEs) – An Overview of Immunosuppressive Therapies. Canadian Rheumatology Today. 1, 1 (Apr. 2024), 34–39. DOI:https://doi.org/10.58931/crt.2024.1147.